SXTP
NASDAQ · Pharmaceuticals
60 Degrees Pharma Inc
$1.70
+0.01 (+0.59%)
Open$1.71
Previous Close$1.69
Day High$1.74
Day Low$1.67
52W High$10.77
52W Low$1.22
Volume—
Avg Volume210.6K
Market Cap4.36M
P/E Ratio—
EPS$-9.79
SectorPharmaceuticals
Analyst Ratings
Strong Buy
8 analysts
Price Target
+56.5% upside
Current
$1.70
$1.70
Target
$2.66
$2.66
$2.13
$2.66 avg
$3.16
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 5.59M | 3.99M | 862.6K |
| Net Income | -29,223,718 | -18,758,538 | 198.9K |
| Profit Margin | -522.7% | -496.6% | 23.1% |
| EBITDA | -30,612,930 | -20,741,946 | 334.7K |
| Free Cash Flow | — | — | 224.8K |
| Rev Growth | +40.2% | +40.2% | -6.7% |
| Debt/Equity | 0.04 | 0.04 | 0.52 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,124.85 | +0.68% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $245.14 | +1.72% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $124.71 | +3.41% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $23.83 | -0.87% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.00 | -0.95% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $77.65 | -0.67% | 12.5 | 33.00B |